首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.
【24h】

Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.

机译:在心室辅助设备支持下的晚期心力衰竭患者中,β1-肾上腺素能受体的选择性上调和肌钙蛋白I的去磷酸化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In terminal failing hearts, adrenergic receptors are downregulated and intracellular adrenergic signal transduction is inhibited. Mechanical circulatory support by ventricular assist devices (VAD) is used to bridge patients to heart transplantation. Mechanical unloading by VAD may induce reverse remodeling in heart transplantation (HTx) candidates. However, little is known on beta-adrenergic receptor subtype regulation and adrenergic signal transduction under VAD-support. We investigated paired myocardial samples from 16 VAD-supported patients and 9 non-failing donor hearts. We analyzed beta-adrenergic receptor subtype regulation by real-time PCR and radioligand binding and cardiac troponin I phosphorylation (by phospho-cTnI-specific antibodies). We found that the beta1-adrenergic receptor (beta1AR) is downregulated at VAD-implantation on mRNA and protein levels whereas the beta2-adrenergic receptor (beta2AR) was not. After VAD-support, beta1AR protein but not its mRNA was upregulated, whereas the degree of cTnI-phosphorylation was reduced. Upregulation of beta1AR was enhanced by beta blocking medication during VAD-support. However, in 9 out of 15 patients, beta1AR-density remained below the 0.25 percentile of donor hearts. VAD-support is associated with partial normalization of the betaAR-signal transduction pathways. This beneficial effect is related to a posttranscriptional increase in beta1AR-density.
机译:在末梢衰竭的心脏中,肾上腺素能受体被下调并且细胞内肾上腺素能信号传导被抑制。通过心室辅助设备(VAD)进行的机械循环支持可将患者桥接至心脏移植。 VAD的机械卸载可能会导致心脏移植(HTx)候选对象发生逆向重塑。然而,关于β-肾上腺素受体亚型调节和在VAD支持下的肾上腺素信号转导知之甚少。我们调查了来自16个VAD支持的患者和9个未失败的供体心脏的配对心肌样本。我们通过实时PCR和放射性配体结合以及心肌肌钙蛋白I磷酸化(通过磷酸cTnI特异性抗体)分析了β-肾上腺素受体亚型的调控。我们发现β1-肾上腺素受体(beta1AR)在VAD植入时在mRNA和蛋白质水平上被下调,而β2-肾上腺素受体(beta2AR)则没有。 VAD支持后,beta1AR蛋白而非其mRNA上调,而cTnI磷酸化的程度降低。在VAD支持期间,β受体阻断药可增强beta1AR的上调。然而,在15名患者中,有9名患者的beta1AR密度仍低于供体心脏的0.25%。 VAD支持与betaAR信号转导通路的部分正常化相关。这种有益的作用与beta1AR密度的转录后增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号